Stocks
Bristol-Myers Squibb CompanyBMY
NYSEHealthcarePharmaceuticals$59.08+0.22%
A global biopharmaceutical manufacturer focused on developing and commercializing prescription medicines for cancer, cardiovascular disease, immunology, and other serious conditions. Its portfolio includes blockbuster therapies such as the cancer immunotherapy Opdivo and the anticoagulant Eliquis, w...
Market Cap: $120.3B52W Range: $42.52 – $62.89
Congressional Interest in Bristol-Myers Squibb Company (BMY)
14 members of Congress have disclosed 50 trades in Bristol-Myers Squibb Company (BMY), a Healthcare company. The buy/sell breakdown shows 25 purchases versus 25 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
14
Buys
25
Sells
25
Who in Congress Is Trading BMY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-01-31 | Kurt Schrader | buy | $1K – $15K |
| 2017-01-26 | JAMES B. RENACCI | sell | $15K – $50K |